✦ LIBER ✦

PND28 Cost-Effectiveness Analysis of Interferons and Glatiramer Acetate as First Line Treatments in Remitting – Relapsing Multiple Sclerosis Spanish Patients

✍ Scribed by R. Sánchez-de la Rosa; E. Sabater; M.A. Casado

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND8 COST-EFFECTIVENESS ANALYSIS OF REBI

✍ MJ Nuijten; T Mittendorf; A Jäcker; U Osowski 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB

PND13 A COST-EFFECTIVENESS ANALYSIS OF N

✍ R Gani; ER Samuels; S Hughes; G Giovanonni 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PND8 COST-EFFECTIVENESS AND BUDGET IMPAC

✍ O Espallardo; C Crespo; C Polanco; D Nieves 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Effects of glatiramer acetate on spastic

✍ José Eustasio Meca-Lallana; Pedro de Mingo-Casado; Manuel Amorin-Díaz; María Lui 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 95 KB

PND2 Cost Offsets and Gains in Health Ef

✍ M. Ekman; R.E. White; P.E. Buck; N. Justo; P Lindgren 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB